Sign Out
Coronary Heart Disease: In patients with coronary heart disease and hypercholesterolemia to decrease the risk of death; decrease the risk of fatal and non fatal myocardial infarction; decrease the incidence of stroke and transient ischemic attacks; decrease the risk of undergoing myocardial revascularization procedures (coronary artery bypass grafting and coronary angioplasty); slow the progression of coronary atherosclerosis.
Hyperlipidemia: To decrease total cholesterol, LDL-cholesterol, apolipoprotein B and triglyceride concentrations in the treatment of primary hypercholesterolemia (heterozygous familial and non-familial), homozygous familial hypercholesterolemia and mixed dyslipidemia.
